Nantahala Capital Management, LLC
Registered adviserRegulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
| Rosters | Regulatory AUM | Main clients |
|---|---|---|
| Apr 2026 to Oct 2026 | $3,114,082,769 | Pooled investment vehicles (100%) |
| Apr 2025 to Mar 2026 | $2,345,132,702 | Pooled investment vehicles (100%) |
| Apr 2024 to Mar 2025 | $2,283,111,910 | Pooled investment vehicles (99%) |
| May 2023 to Mar 2024 | $2,470,541,928 | Pooled investment vehicles (100%) |
| Apr 2023 | $2,470,541,928 | Pooled investment vehicles (100%) |
| Apr 2022 to Mar 2023 | $3,539,081,537 | Pooled investment vehicles (100%) |
Portfolio style
Measured from the filed 13F common-share book for Jun 30, 2026, never from the firm's own description.
Closest benchmark: the Russell 2000 as of 2026-06-30, active share 97.8%; sector active share 60.9% against the combined 13F book's sector weights.
Over time 26 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
140 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Portfolio Trend
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 44.8% | $1,348,552,461 |
| Unclassified | 23.3% | $701,079,740 |
| Consumer Cyclical | 15.3% | $459,220,215 |
| Financial Services | 4.7% | $140,569,295 |
| Consumer Defensive | 4.2% | $125,816,810 |
| Communication Services | 3.0% | $89,076,987 |
| Industrials | 1.6% | $49,121,266 |
| Real Estate | 1.5% | $44,102,190 |
| Technology | 1.3% | $38,897,628 |
| Basic Materials | 0.4% | $13,344,126 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ADCT | ADC Therapeutics SA | +6,728,751 | 12,326,184 | $13,189,016 | |
| FULC | Fulcrum Therapeutics, Inc. | +2,425,000 | 5,475,040 | $20,038,646 | |
| ALEC | Alector, Inc. | +1,502,126 | 4,318,109 | $8,679,399 | |
| IRD | Opus Genetics, Inc. | +1,380,029 | 3,061,359 | $12,582,185 | |
| MDXG | Mimedx Group, Inc. | +1,370,253 | 4,767,552 | $18,355,075 | |
| GERN | Geron Corp | +1,000,000 | 12,225,000 | $15,648,000 | |
| AURA | Aura Biosciences, Inc. | +833,333 | 2,951,030 | $20,952,313 | |
| TELA | TELA Bio, Inc. | +750,000 | 5,894,114 | $4,420,585 | |
| AVTX | Avalo Therapeutics, Inc. | +627,250 | 1,862,250 | $34,414,380 | |
| HLSQ | Tessera Defense & Homeland Security Inc. | +520,200 | 634,995 | $215,232 | |
| UNCY | Unicycive Therapeutics, Inc. | +462,245 | 1,401,447 | $6,572,786 | |
| AGMB | AgomAb Therapeutics NV | +368,188 | 1,568,188 | $20,355,080 | |
| QURE | uniQure N.V. | +218,582 | 455,660 | $20,987,699 | |
| JACK | Jack In The Box Inc | +185,944 | 1,728,659 | $27,330,098 | |
| IMAX | Imax Corp | +142,455 | 658,009 | $26,228,238 | |
| TRDA | Entrada Therapeutics, Inc. | +141,243 | 300,575 | $2,212,232 | |
| ABEO | Abeona Therapeutics Inc. | +123,438 | 5,136,490 | $31,743,508 | |
| FOSL | Fossil Group, Inc. | +101,104 | 5,505,128 | $22,791,229 | |
| LXEO | Lexeo Therapeutics, Inc. | +100,000 | 1,300,000 | $6,051,500 | |
| RYAM | Rayonier Advanced Materials Inc. | +97,726 | 1,697,726 | $13,344,126 | |
| FORR | Forrester Research, Inc. | +69,024 | 763,446 | $6,420,580 | |
| KROS | Keros Therapeutics, Inc. | +50,000 | 1,410,419 | $15,091,483 | |
| BNTC | Benitec Biopharma Inc. | +50,000 | 1,488,371 | $19,914,403 | |
| KIDS | Orthopediatrics Corp | +42,893 | 242,342 | $4,636,002 | |
| DRIO | DarioHealth Corp. | +1 | 610,691 | $4,030,560 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PTON | Peloton Interactive, Inc. | −6,891,005 | 5,108,995 | $30,194,160 | |
| IMUX | Immunic, Inc. | −2,255,845 | 250,646 | $3,852,429 | |
| AVR | Anteris Technologies Global Corp. | −2,147,575 | 3,383,335 | $33,325,849 | |
| GUTS | Fractyl Health, Inc. | −2,075,423 | 11,289,096 | $8,963,542 | |
| SVC | Service Properties Trust | −1,735,246 | 5,322,641 | $8,995,263 | |
| BRCC | BRC Inc. | −1,373,346 | 1,257,171 | $1,395,459 | |
| TLSI | TriSalus Life Sciences, Inc. | −1,070,827 | 1,000,000 | $4,550,000 | |
| SLN | Silence Therapeutics plc | −800,000 | 1,346,731 | $14,787,106 | |
| EOLS | Evolus, Inc. | −774,836 | 5,602,021 | $38,878,025 | |
| TNGX | Tango Therapeutics, Inc. | −749,793 | 500,659 | $15,650,600 | |
| ZVRA | Zevra Therapeutics, Inc. | −724,460 | 1,797,476 | $25,775,805 | |
| CWH | Camping World Holdings, Inc. | −708,219 | 2,551,055 | $19,464,549 | |
| AMRX | Amneal Pharmaceuticals, Inc. | −575,357 | 2,268,751 | $39,272,079 | |
| ILPT | Industrial Logistics Properties Trust | −567,820 | 1,111,153 | $9,855,927 | |
| CDXS | Codexis, Inc. | −500,000 | 3,623,613 | $8,189,365 | |
| VENU | Venu Holding Corp | −500,000 | 1,546,705 | $3,511,020 | |
| ESTA | Establishment Labs Holdings Inc. | −497,126 | 335,830 | $28,817,572 | |
| HGV | Hilton Grand Vacations Inc. | −480,486 | 1,033,170 | $54,107,112 | |
| SVRA | Savara Inc | −367,973 | 6,976,810 | $42,977,149 | |
| VMD | Viemed Healthcare, Inc. | −251,338 | 632,445 | $7,209,873 | |
| HLF | Herbalife Ltd. | −244,499 | 1,109,154 | $14,585,375 | |
| ALTG | Alta Equipment Group Inc. | −210,000 | 724,774 | $4,689,287 | |
| GOGO | Gogo Inc. | −184,305 | 8,697,731 | $26,962,966 | |
| FOXF | Fox Factory Holding Corp | −177,605 | 1,310,695 | $22,209,726 | |
| APYX | Apyx Medical Corp | −170,056 | 3,270,248 | $14,683,413 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ADMA | Adma Biologics, Inc. | 2,359,993 | $19,753,141 | |
| VOR | Vor Biopharma Inc. | 845,000 | $15,556,450 | |
| PLNT | Planet Fitness, Inc. | 279,000 | $14,555,430 | |
| AMAN | Amanat Acquisition Corp. | 1,200,000 | $12,192,000 | |
| INSP | Inspire Medical Systems, Inc. | 269,474 | $12,021,235 | |
| IVA | Inventiva S.A. | 2,686,393 | $10,154,565 | |
| CATX | Perspective Therapeutics, Inc. | 2,325,450 | $7,929,784 | |
| IACQ | Irenic Acquisition Corp. | 750,000 | $7,492,500 | |
| ELOX | Eloxx Pharmaceuticals, Inc. | 400,000 | $5,552,000 | |
| TRAX | First Tracks Biotherapeutics, Inc. | 250,000 | $5,030,000 | |
| ALT | Altimmune, Inc. | 1,500,000 | $4,560,000 | |
| ZLAB | Zai Lab Ltd | 200,000 | $3,800,000 | |
| KLRA | Kailera Therapeutics, Inc. | 140,000 | $3,084,200 | |
| ARTV | Artiva Biotherapeutics, Inc. | 300,000 | $2,910,000 | |
| EDIT | Editas Medicine, Inc. | 852,700 | $2,762,748 | |
| JATT | JATT II Acquisition Corp. | 225,000 | $2,556,000 | |
| ALXO | Alx Oncology Holdings Inc | 750,000 | $1,552,500 | |
| SNAP | Snap Inc | 200,000 | $888,000 | |
| CLRB | Cellectar Biosciences, Inc. | 219,998 | $611,594 | |
| AZTR | Azitra, Inc. | 2,213,613 | $371,444 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| — | 1,744,124 | $58,393,272 | ||
| — | 692,335 | $13,195,905 | ||
| CNTA | Centessa Pharmaceuticals plc | 254,803 | $10,120,775 | |
| COGT | Cogent Biosciences, Inc. | 250,000 | $9,622,500 | |
| SLDB | Solid Biosciences Inc. | 1,165,078 | $8,388,561 | |
| DNTH | Dianthus Therapeutics, Inc. | 67,282 | $5,646,305 | |
| KOS | Kosmos Energy Ltd. | 1,844,194 | $5,126,859 | |
| RVMD | Revolution Medicines, Inc. | 50,000 | $4,862,500 | |
| CZR | Caesars Entertainment, Inc. | 150,000 | $3,964,500 | |
| UPB | Upstream Bio, Inc. | 400,000 | $3,600,000 | |
| NNBR | Nn Inc | 2,441,416 | $3,540,053 | |
| GRCE | Grace Therapeutics, Inc. | 728,203 | $3,371,579 | |
| CGON | CG Oncology, Inc. | 49,449 | $3,346,708 | |
| XNCR | Xencor Inc | 264,639 | $3,191,546 | |
| ACHV | Achieve Life Sciences, Inc. | 648,885 | $1,907,721 | |
| IRON | Disc Medicine, Inc. | 25,653 | $1,640,252 | |
| PEPG | PepGen Inc. | 681,158 | $1,205,649 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| IWM |
iShares Russell 2000 ETF
PUT
|
Reduced | 2,000,000 | $600,900,000 | 19.96% | |
| PTON |
Peloton Interactive, Inc.
CALL
+ SHARES
Consumer Cyclical
|
Reduced | 21,547,895 | $127,348,059 | 4.23% | |
| HGV |
Hilton Grand Vacations Inc.
CALL
+ SHARES
Consumer Cyclical
|
Reduced | 2,108,170 | $110,404,862 | 3.67% | |
| HLF |
Herbalife Ltd.
CALL
+ SHARES
Consumer Defensive
|
Added | 7,709,154 | $101,375,375 | 3.37% | |
| TBBK |
Bancorp, Inc.
CALL
+ SHARES
Financial Services
|
Reduced | 1,365,687 | $85,546,633 | 2.84% | |
| VTRS |
Viatris Inc
CALL
Healthcare
|
Held | 5,000,000 | $79,400,000 | 2.64% | |
| EW |
Edwards Lifesciences Corp
PUT
Healthcare
|
Held | 800,000 | $72,368,000 | 2.40% | |
| QURE |
uniQure N.V.
PUT
CALL
+ SHARES
Healthcare
|
Reduced | 1,417,160 | $65,274,389 | 2.17% | |
| XBI |
State Street(R) SPDR(R) S&P(R) Biotech ETF
PUT
|
Added | 400,000 | $63,300,000 | 2.10% | |
| BVS |
Bioventus Inc.
Healthcare
|
Reduced | 6,000,279 | $56,642,633 | 1.88% | |
| SVRA |
Savara Inc
Healthcare
|
Reduced | 6,976,810 | $42,977,149 | 1.43% | |
| ETON |
Eton Pharmaceuticals, Inc.
Healthcare
|
Held | 1,175,951 | $42,569,426 | 1.41% | |
| AMRX |
Amneal Pharmaceuticals, Inc.
Healthcare
|
Reduced | 2,268,751 | $39,272,079 | 1.30% | |
| EOLS |
Evolus, Inc.
Healthcare
|
Reduced | 5,602,021 | $38,878,025 | 1.29% | |
| ABEO |
Abeona Therapeutics Inc.
CALL
+ SHARES
Healthcare
|
Added | 6,156,490 | $38,047,108 | 1.26% | |
|
PUT
|
NEW | 223,000 | $36,879,740 | 1.23% | ||
| FOXF |
Fox Factory Holding Corp
CALL
+ SHARES
Consumer Cyclical
|
Reduced | 2,110,695 | $35,765,726 | 1.19% | |
| CWH |
Camping World Holdings, Inc.
CALL
+ SHARES
Consumer Cyclical
|
Reduced | 4,551,055 | $34,724,549 | 1.15% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
Added | 1,862,250 | $34,414,380 | 1.14% | |
| LBRX |
Lb Pharmaceuticals Inc
Healthcare
|
Held | 1,052,894 | $34,171,674 | 1.14% | |
| NBIX |
Neurocrine Biosciences Inc
CALL
Healthcare
|
NEW | 200,000 | $33,708,000 | 1.12% | |
| PRAX |
Praxis Precision Medicines, Inc.
PUT
Healthcare
|
NEW | 100,000 | $33,479,000 | 1.11% | |
| AVR |
Anteris Technologies Global Corp.
Healthcare
|
Reduced | 3,383,335 | $33,325,849 | 1.11% | |
| RDNW |
RideNow Group, Inc.
CALL
+ SHARES
Consumer Cyclical
|
Held | 4,972,845 | $33,119,147 | 1.10% | |
| KRYS |
Krystal Biotech, Inc.
PUT
Healthcare
|
NEW | 85,000 | $31,591,950 | 1.05% | |
| ESTA |
Establishment Labs Holdings Inc.
Healthcare
|
Reduced | 335,830 | $28,817,572 | 0.96% | |
| XTNT |
Xtant Medical Holdings, Inc.
Healthcare
|
Held | 68,394,000 | $28,725,480 | 0.95% | |
| JACK |
Jack In The Box Inc
Consumer Cyclical
|
Added | 1,728,659 | $27,330,098 | 0.91% | |
| GOGO |
Gogo Inc.
Communication Services
|
Reduced | 8,697,731 | $26,962,966 | 0.90% | |
| IMAX |
Imax Corp
Communication Services
|
Added | 658,009 | $26,228,238 | 0.87% | |
| ZVRA |
Zevra Therapeutics, Inc.
Healthcare
|
Reduced | 1,797,476 | $25,775,805 | 0.86% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
CALL
Healthcare
|
Held | 40,000 | $24,941,600 | 0.83% | |
| TITN |
Titan Machinery Inc.
Industrials
|
Reduced | 1,133,088 | $23,930,818 | 0.80% | |
| RMR |
Rmr Group Inc.
Real Estate
|
Held | 1,147,902 | $23,566,428 | 0.78% | |
| FOSL |
Fossil Group, Inc.
Consumer Cyclical
|
Added | 5,505,128 | $22,791,229 | 0.76% | |
| SNAP |
Snap Inc
CALL
+ SHARES
Communication Services
|
NEW | 5,000,000 | $22,200,000 | 0.74% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Reduced | 820,481 | $22,136,577 | 0.74% | |
| AURA |
Aura Biosciences, Inc.
Healthcare
|
Added | 2,951,030 | $20,952,313 | 0.70% | |
| AGMB |
AgomAb Therapeutics NV
Healthcare
|
Added | 1,568,188 | $20,355,080 | 0.68% | |
| FULC |
Fulcrum Therapeutics, Inc.
Healthcare
|
Added | 5,475,040 | $20,038,646 | 0.67% | |
| BNTC |
Benitec Biopharma Inc.
Healthcare
|
Added | 1,488,371 | $19,914,403 | 0.66% | |
| ADMA |
Adma Biologics, Inc.
Healthcare
|
NEW | 2,359,993 | $19,753,141 | 0.66% | |
| BCRX |
Biocryst Pharmaceuticals Inc
Healthcare
|
Reduced | 1,901,160 | $19,011,600 | 0.63% | |
| MDXG |
Mimedx Group, Inc.
Healthcare
|
Added | 4,767,552 | $18,355,075 | 0.61% | |
| ABVX |
Abivax S.A.
Healthcare
|
Reduced | 133,759 | $17,824,724 | 0.59% | |
| USNA |
Usana Health Sciences Inc
Consumer Defensive
|
Held | 810,074 | $17,295,079 | 0.57% | |
| CHYM |
Chime Financial, Inc.
CALL
+ SHARES
Technology
|
Reduced | 772,119 | $15,812,997 | 0.53% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
Held | 651,993 | $15,778,230 | 0.52% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
Reduced | 500,659 | $15,650,600 | 0.52% | |
| GERN |
Geron Corp
Healthcare
|
Added | 12,225,000 | $15,648,000 | 0.52% |
Showing the top 50 of 140 positions. Create a free account to see every position, past quarters, search, filters and CSV export.
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.